Barclays Maintains Overweight on Arvinas, Raises Price Target to $20

Benzinga Newsdesk www.benzinga.com Positive 77.2%

Neg 0% Neu 0% Pos 77.2%

Barclays analyst Etzer Darout maintains Arvinas (NASDAQ:ARVN) with a Overweight and raises the price target from $18 to $20.